Mpox: Combating a Dangerous Pathogen

Introduction

The coronavirus pandemic is far from over. Already another virus is causing a stir: "International outbreak of mpox" was the cry in the media a few weeks ago, followed by daily headlines along the lines of "first case of mpox in Baden-Württemberg, Bavaria, Berlin and so on". Subsequent reports, like that of Bavaria's public broadcasting service Bayerischer Rundfunk - "Study: mpox pathogen mutates faster than expected" - or that of the German weekly news magazine Der Spiegel - "Doctor says of mpox: 'We have gone past the point in time where the virus could still have been stopped completely'", did nothing to calm the situation.

Main Item

And at the latest, since the World Health Organisation (WHO) declared the mpox outbreak in more than 50 countries an "emergency of international concern" on 23 July, it should be clear to everyone: Viruses can cross species barriers at any time and cause novel diseases, known as zoonoses, in humans. In extreme cases, they can even trigger another pandemic.

Innovative Approaches to Drug Development

Given this context, it seems more than fitting that the University of Würzburg (JMU) is launching a new research project dealing with this topic. "A structure-based approach to combat zoonotic poxviruses" is its title.

This project, with around EUR 700,000 from the Volkswagen Foundation, is headed by Professor Utz Fischer, Chair of Biochemistry at JMU, and his colleague Dr. Clemens Grimm. Also on board is Intana Bioscience GmbH, a biotech company based near Munich with a special interest in developing new agents. Poxviruses are the focus of this project.

Poxviruses Carry a High Risk Potential

"We know that animals carry many types of viruses in their organism that can pose a threat to humans," says Utz Fischer.

Unfortunately, it is impossible to predict which of them will be the next to make the jump across species barriers. However, it is clear that some viruses have a higher potential than others and are therefore more threatening to humanity, with poxviruses right at the top of this list. Therefore, the project aims to conceive new approaches to developing novel drugs against pox pathogens. To this end, scientists are looking for substances that interfere with the viral transcription process and thus prevent the viruses from multiplying.

Fischer and his team can draw on findings they presented to the public last autumn.

"We succeeded in visualizing the poxviral gene expression machinery at the atomic level," explains the biochemist.

These studies, therefore, allow observing how the molecular machinery acts when the virus multiplies. The images show how the players involved operate during the early phase of transcription.

Approach Can Also be Applied to Swine Fever

With the search for agents that can inhibit these molecular machines, the team can exploit a special circumstance: While many viruses draw extensively on the biochemical resources of the host cell for their multiplication, poxviruses encode their molecular machinery in their genome for this purpose. Important components of this machinery are two enzymes: DNA polymerase, which multiplies the viral genes, and RNA polymerase, which transcribes the viral genes into mRNA.

This unique replication strategy offers the opportunity to search for inhibitors of key viral complexes and enzymes that attack at this exact point and thus spare the host cells, ideally making them free from side effects. Should the team succeed in identifying and designing such molecules, they might even kill two birds with one stone:

"Because the transcription machinery of Poxviridae and Asfarviridae are highly similar, our research is also likely to be of relevance for the economically highly threatening Asfarvirus-linked swine fever disease," says Fischer.

Technical Progress Helps the Research

Technical advances are most helpful to scientists in their work. One of these is a significant increase in the resolution of cryo-electron microscopic images. This technology makes samples "flash-frozen" to temperatures of up to minus 180 degrees Celsius. This makes it possible to examine biological molecules and complexes in solution and reconstruct their three-dimensional structure on the scale of atoms.

The JMU has had a suitable electron microscope for many years.

"Many medically relevant target molecules are becoming the focus of drug design. We will use this technology and established methods to identify molecules that target the special structures of poxviruses and disrupt their multiplication," Clemens Grimm explains.

He carries out structural biology analyses at the department.

Indeed, the scientists involved are optimistic that they will succeed over the coming years in defining several chemical compounds that can serve as a guiding structure for the subsequent development of a pharmaceutical product.

Poxviruses are a Threat for Several Reasons

It is, of course, a coincidence that the research team is starting its work at the same time as this outbreak of mpox - the application was written months ago. But what is not a coincidence that scientists focus on poxviruses? After all, these pose a potential threat to humanity for various reasons. For one thing, very few antiviral drugs are currently available, and these often display minimal potency.

In addition, while there is an effective protection against pox infection in the form of vaccination after the World Health Organization (WHO) declared smallpox eradicated in 1980, the corresponding vaccination campaigns were terminated in the ensuing years. Since then, herd immunity to poxviruses has been noticeably dwindling in humans. It is no wonder that a recent study ranks the mpox virus as one of the most threatening viruses because of the risk of infecting humans, adapting to its new host through mutations, and then spreading exponentially.

Attribution/Source(s):

This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by University of Würzburg, and published on 2022/08/01 (Edit Update: 2024/04/18), the content may have been edited for style, clarity, or brevity. For further details or clarifications, University of Würzburg can be contacted at uni-wuerzburg.de/en/home/. NOTE: Disabled World does not provide any warranties or endorsements related to this article.

▶ Share This Page

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): University of Würzburg. (2022, August 1 - Last revised: 2024, April 18). Mpox: Combating a Dangerous Pathogen. Disabled World. Retrieved October 16, 2024 from www.disabled-world.com/health/monkeypox/pathogen.php

Permalink: <a href="https://www.disabled-world.com/health/monkeypox/pathogen.php">Mpox: Combating a Dangerous Pathogen</a>: Scientists are looking for substances that interfere with the viral transcription process and thus prevent the viruses from multiplying.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.